These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29345921)

  • 21. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
    Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
    J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro COX-1 and COX-2 enzyme inhibitory activities of iridoids from Penstemon barbatus, Castilleja tenuiflora, Cresentia alata and Vitex mollis.
    Ramírez-Cisneros MÁ; Rios MY; Aguilar-Guadarrama AB; Rao PP; Aburto-Amar R; Rodríguez-López V
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4505-8. PubMed ID: 26351040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies.
    Abdel-Aziz AA; El-Azab AS; Abou-Zeid LA; ElTahir KE; Abdel-Aziz NI; Ayyad RR; Al-Obaid AM
    Eur J Med Chem; 2016 Jun; 115():121-31. PubMed ID: 26999325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors.
    Gierse JK; McDonald JJ; Hauser SD; Rangwala SH; Koboldt CM; Seibert K
    J Biol Chem; 1996 Jun; 271(26):15810-4. PubMed ID: 8663121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bitter barricading of prostaglandin biosynthesis pathway: understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita.
    Shukla S; Bafna K; Sundar D; Thorat SS
    PLoS One; 2014; 9(6):e90637. PubMed ID: 24603686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2 selectivity and inflammatory processes.
    van Ryn J; Trummlitz G; Pairet M
    Curr Med Chem; 2000 Nov; 7(11):1145-61. PubMed ID: 11032964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
    Cronstein BN
    Cleve Clin J Med; 2002; 69 Suppl 1():SI13-9. PubMed ID: 12086289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors.
    Scholz M; Blobaum AL; Marnett LJ; Hey-Hawkins E
    Bioorg Med Chem; 2011 May; 19(10):3242-8. PubMed ID: 21524587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular docking-guided synthesis of NSAID-glucosamine bioconjugates and their evaluation as COX-1/COX-2 inhibitors with potentially reduced gastric toxicity.
    Jones Lipinski RA; Thillier Y; Morisseau C; Sebastiano CS; Smith BC; Hall CD; Katritzky AR
    Chem Biol Drug Des; 2021 Jul; 98(1):102-113. PubMed ID: 33955172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety.
    Sağlık BN; Osmaniye D; Levent S; Çevik UA; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
    Eur J Med Chem; 2021 Jan; 209():112918. PubMed ID: 33071054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition.
    Altıntop MD; Sever B; Akalın Çiftçi G; Ertorun İ; Alataş Ö; Özdemir A
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200136. PubMed ID: 35606682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of Santonin to a Naproxen Analogue with Anti-Inflammatory Activity.
    Singh R; Mandrah K; Asati A; Patel DK; Goel B; Vishwakarma RA; Roy SK; Jain SK
    J Nat Prod; 2019 Jun; 82(6):1710-1713. PubMed ID: 31125226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer: synthesis and biological studies.
    Bhardwaj A; Kaur J; Wuest F; Knaus EE
    ChemMedChem; 2014 Jan; 9(1):109-16, 240. PubMed ID: 24376205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
    Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacology of selective COX-2 inhibitors.
    Capone ML; Tacconelli S; Sciulli MG; Patrignani P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
    Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P
    J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES.
    Hassan GS; Abdel Rahman DE; Abdelmajeed EA; Refaey RH; Alaraby Salem M; Nissan YM
    Eur J Med Chem; 2019 Jun; 171():332-342. PubMed ID: 30928706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase.
    Llorens O; Perez JJ; Palomer A; Mauleon D
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2779-84. PubMed ID: 10522690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insight into the Crystal Structures and Potential of Two Newly Synthesized Naproxen-Based Hydrazide Derivatives as Potent COX-2 Inhibitors.
    Mohamed SK; Ahmad S; Albayati MR; Elgarhy SMI; Lai CH; Mague JT; El Bakri Y
    Appl Biochem Biotechnol; 2022 Dec; 194(12):5781-5807. PubMed ID: 35819690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.